Tech Company Financing Transactions
Karius Funding Round
Karius closed a $50 million Series A financing round on 8/8/2017. Investors included Data Collective, Lightspeed Venture Partners and Innovation Endeavors.
Transaction Overview
Company Name
Announced On
8/8/2017
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Investors
Data Collective (Lead Investor)
Lightspeed Venture Partners (Lead Investor)
Proceeds Purpose
Funds will be used to support ongoing and new clinical trials, scale up laboratory capacity, and advance commercialization of the Karius test, which uses a combination of machine learning, proprietary genomics algorithms, and next-generation sequencing to enable the broad and rapid detection of more than 1,250 pathogens.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
975 Island Dr. 101
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Website
Email Address
Overview
The Karius test harnesses next-generation sequencing to detect fragments of cell-free DNA from bacteria, viruses, fungi and protozoa that may be circulating in a patient's bloodstream.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mickey Kertesz
Chief Medical Officer
Asim Ahmed
Chief Scientific Officer
Timothy Blauwkamp
Chief Technical Officer
Sivan Bercovici
VP - Finance
Karen To
VP - Human Resources
Stacy Solorio
Browse more venture capital transactions:
Prev: 8/8/2017: mLevel venture capital transaction
Next: 8/8/2017: Ancera venture capital transaction
Share this article
News on VC Transactions
We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs